Cardiovascular Considerations in COVID19: A Comprehensive Review

Overview

Journal Ther Clin Risk Manag

Publisher Dove Medical Press

Date 2020 Nov 18

PMID 33204097

Citations 4

Authors

Faeze Keihanian

Leila Bigdelu

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID19) is spreading rapidly and there is now much concern regarding different aspects of public health. Underlying disorders like cardiovascular diseases can increase the mortality rate. Understanding cardiovascular complications, manifestations and management in COVID19 is a necessary need. In this comprehensive review, we evaluated different aspects of cardiovascular disorders or complications related to COVID19 infection.

Citing Articles

Echocardiographic and electrocardiographic findings in COVID-19 patients: a cross-sectional study.

Keihanian F, Poorzand H, Saeidinia A, Eshraghi A Int J Cardiovasc Imaging. 2023; 38(10):2167-2175.

PMID: 37726458 PMC: 9040693. DOI: 10.1007/s10554-022-02617-9.

Iranian traditional medicinal plants for management of chronic heart failure: A review.

Keihanian F, Moohebati M, Saeidinia A, Mohajeri S Medicine (Baltimore). 2023; 102(19):e33636.

PMID: 37171363 PMC: 10174410. DOI: 10.1097/MD.0000000000033636.

Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients.

Beltran-Camacho L, Bhosale S, Sanchez-Morillo D, Sanchez-Gomar I, Rojas-Torres M, Eslava-Alcon S Int J Biol Sci. 2023; 19(6):1664-1680.

PMID: 37063416 PMC: 10092762. DOI: 10.7150/ijbs.78864.

The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.

Beltran-Camacho L, Eslava-Alcon S, Rojas-Torres M, Sanchez-Morillo D, Martinez-Nicolas M, Martin-Bermejo V Mol Med. 2022; 28(1):40.

PMID: 35397534 PMC: 8994070. DOI: 10.1186/s10020-022-00465-w.

References

Zhang Y, Cao W, Xiao M, Li Y, Yang Y, Zhao J . [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia]. Zhonghua Xue Ye Xue Za Zhi. 2020; 41(4):302-307. PMC: 7364914. DOI: 10.3760/cma.j.issn.0253-2727.2020.008. View

Corrales-Medina V, Alvarez K, Weissfeld L, Angus D, Chirinos J, Chang C . Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015; 313(3):264-74. PMC: 4687729. DOI: 10.1001/jama.2014.18229. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020; 191:148-150. PMC: 7192101. DOI: 10.1016/j.thromres.2020.04.041. View

Gao L, Jiang D, Wen X, Cheng X, Sun M, He B . Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020; 21(1):83. PMC: 7156898. DOI: 10.1186/s12931-020-01352-w. View

Driggin E, Madhavan M, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G . Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020; 75(18):2352-2371. PMC: 7198856. DOI: 10.1016/j.jacc.2020.03.031. View

Welt F, Shah P, Aronow H, Bortnick A, Henry T, Sherwood M . Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI. J Am Coll Cardiol. 2020; 75(18):2372-2375. PMC: 7270593. DOI: 10.1016/j.jacc.2020.03.021. View

Mattiuzzi C, Lippi G . Which lessons shall we learn from the 2019 novel coronavirus outbreak?. Ann Transl Med. 2020; 8(3):48. PMC: 7036635. DOI: 10.21037/atm.2020.02.06. View

Talasaz A, Kakavand H, Van Tassell B, Aghakouchakzadeh M, Sadeghipour P, Dunn S . Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective. Cardiovasc Drugs Ther. 2020; 35(2):249-259. PMC: 7360896. DOI: 10.1007/s10557-020-07037-2. View

10.

Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S . Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. PMC: 7121452. DOI: 10.1056/NEJMsr2005760. View

11.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

12.

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

13.

Libby P, Simon D . Inflammation and thrombosis: the clot thickens. Circulation. 2001; 103(13):1718-20. DOI: 10.1161/01.cir.103.13.1718. View

14.

Lippi G, Lavie C, Sanchis-Gomar F . Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020; 63(3):390-391. PMC: 7127395. DOI: 10.1016/j.pcad.2020.03.001. View

15.

Xiong T, Redwood S, Prendergast B, Chen M . Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020; 41(19):1798-1800. PMC: 7454513. DOI: 10.1093/eurheartj/ehaa231. View

16.

Yu C, Wong R, Wu E, Kong S, Wong J, Yip G . Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006; 82(964):140-4. PMC: 2596695. DOI: 10.1136/pgmj.2005.037515. View

17.

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

18.

Giudicessi J, Noseworthy P, Friedman P, Ackerman M . Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc. 2020; 95(6):1213-1221. PMC: 7141471. DOI: 10.1016/j.mayocp.2020.03.024. View

19.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

20.

Kir D, Mohan C, Sancassani R . Heart Brake: An Unusual Cardiac Manifestation of COVID-19. JACC Case Rep. 2020; 2(9):1252-1255. PMC: 7196413. DOI: 10.1016/j.jaccas.2020.04.026. View